PSMA-PET provides long-term benefits
AuntMinnie
OCTOBER 24, 2024
Prostate-specific membrane antigen (PSMA) PET imaging could improve the length and quality of life for patients with recurrent prostate cancer, according to a study published October 23 in JAMA Network Open. In a modeling study of simulated patients, compared with conventional imaging, PSMA-PET was estimated to lead to fewer deaths from prostate cancer, more life years, and more quality-adjusted life years (QALYs) per 1,000 patients.
Let's personalize your content